Edison Investment Research is terminating coverage on e-therapeutics (ETX). Please note you should no longer rely on any previous research or estimates for this company. All forecasts should now be considered redundant.
Healthcare |
edison tv
Healthcare |
Update
Healthcare |
Initiation